Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label ESR1-Mutated Advanced or Metastatic Breast Cancer. Show all posts
Showing posts with label ESR1-Mutated Advanced or Metastatic Breast Cancer. Show all posts
Thursday, October 30, 2025

FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

›
Eli Lilly and Company (NYSE: LLY) announced  the U.S. Food and Drug Administration (FDA)  approval of  Inluriyo (imlunestrant, 200 mg tablet...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.